Principal Investigator
Matthew Schlumbrecht
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230316
Clinical Trial Summary
Prospective, Single-Arm, Multicenter Study Evaluating Safety, Tolerability, and Metabolism of Niraparib as Maintenance following Front-Line Treatment for Ovarian Cancer in Women of African Ancestry
Phase
Phase IV
Funding Agency/Sponsor
Institutional
Disease
Gynecologic Cancer
Contact Information
Phone Number
+1 (305) 2434624